IDSA: Maternal RSVpreF Vaccine Would Cut Clinical, Economic Burden

MONDAY, Oct. 16, 2023 -- Maternal vaccination with a bivalent stabilized prefusion F subunit respiratory syncytial virus (RSV) vaccine (RSVpreF) is projected to reduce the clinical and economic burden of RSV lower respiratory tract illness (LRTI) in...